AAAAAA

   
Results: 1-11 |
Results: 11
LIVER-FAILURE AND MORTALITY IN HIV-POSITIVE HEMOPHILIACS - 14-YEAR EXPERIENCE AND LITERATURE-REVIEW
Authors: SCHWARTZ JD ALEDORT LM SEREMETIS SV
Citation: Jd. Schwartz et al., LIVER-FAILURE AND MORTALITY IN HIV-POSITIVE HEMOPHILIACS - 14-YEAR EXPERIENCE AND LITERATURE-REVIEW, Haemophilia, 3(1), 1997, pp. 24-30
DESMOPRESSIN NASAL SPRAY FOR HEMOPHILIA-A AND TYPE-I VON-WILLEBRAND-DISEASE
Authors: SEREMETIS SV ALEDORT LM
Citation: Sv. Seremetis et Lm. Aledort, DESMOPRESSIN NASAL SPRAY FOR HEMOPHILIA-A AND TYPE-I VON-WILLEBRAND-DISEASE, Annals of internal medicine, 126(9), 1997, pp. 744-745
VIOLENCE AND WOMEN - CASE PRESENTATION AND DISCUSSION
Authors: SEREMETIS SV
Citation: Sv. Seremetis, VIOLENCE AND WOMEN - CASE PRESENTATION AND DISCUSSION, The Mount Sinai journal of medicine, 63(2), 1996, pp. 103-104
VIOLENCE AND THE PHYSICIANS DUTY - A PANEL DISCUSSION
Authors: MOROS DA GIVELBAR D GERT B BARON BA EISER AR JACOBSON S LIFTON RJ PARIS BEC BAUMRIN B RABIN E ROBICHAUD A SEREMETIS SV GRIMM KT
Citation: Da. Moros et al., VIOLENCE AND THE PHYSICIANS DUTY - A PANEL DISCUSSION, The Mount Sinai journal of medicine, 63(2), 1996, pp. 107-110
MODERN TREATMENT OF HEMOPHILIA - CHOICE OF PRODUCTS FOR THE TREATMENTOF HEMOPHILIA-A AND HEMOPHILIA-B
Authors: SEREMETIS SV
Citation: Sv. Seremetis, MODERN TREATMENT OF HEMOPHILIA - CHOICE OF PRODUCTS FOR THE TREATMENTOF HEMOPHILIA-A AND HEMOPHILIA-B, Haemophilia, 1, 1995, pp. 21-25
IMPACT OF HEMOPHILIA TREATMENT ON THE MANAGEMENT OF HIV DISEASE
Authors: SEREMETIS SV
Citation: Sv. Seremetis, IMPACT OF HEMOPHILIA TREATMENT ON THE MANAGEMENT OF HIV DISEASE, AIDS patient care, 8, 1994, pp. 190000010-190000013
RISKS OF IMMUNODEFICIENCY, AIDS, AND DEATH RELATED TO PURITY OF FACTOR-VIII CONCENTRATE
Authors: GOEDERT JJ COHEN AR KESSLER CM EICHINGER S SEREMETIS SV RABKIN CS YELLIN FJ ROSENBERG PS ALEDORT LM
Citation: Jj. Goedert et al., RISKS OF IMMUNODEFICIENCY, AIDS, AND DEATH RELATED TO PURITY OF FACTOR-VIII CONCENTRATE, Lancet, 344(8925), 1994, pp. 791-792
THE CLINICAL USE OF FACTOR VIIA IN THE TREATMENT OF FACTOR-VIII INHIBITOR PATIENTS
Authors: SEREMETIS SV
Citation: Sv. Seremetis, THE CLINICAL USE OF FACTOR VIIA IN THE TREATMENT OF FACTOR-VIII INHIBITOR PATIENTS, Seminars in hematology, 31(2), 1994, pp. 53-55
3-YEAR RANDOMIZED STUDY OF HIGH-PURITY OR INTERMEDIATE-PURITY FACTOR-VIII CONCENTRATES IN SYMPTOM-FREE HIV-SEROPOSITIVE HEMOPHILIACS - EFFECTS ON IMMUNE STATUS
Authors: SEREMETIS SV ALEDORT LM BERGMAN GE BONA R BRAY G BRETTLER D EYSTER ME KESSLER C LAU TS LUSHER J RICKLES F
Citation: Sv. Seremetis et al., 3-YEAR RANDOMIZED STUDY OF HIGH-PURITY OR INTERMEDIATE-PURITY FACTOR-VIII CONCENTRATES IN SYMPTOM-FREE HIV-SEROPOSITIVE HEMOPHILIACS - EFFECTS ON IMMUNE STATUS, Lancet, 342(8873), 1993, pp. 700-703
VERY HIGH-PURITY VERSUS INTERMEDIATE-PURITY FACTOR-VIII IN HUMAN-IMMUNODEFICIENCY-VIRUS POSITIVE HEMOPHILIACS - CONCLUSIONS OF A PROSPECTIVE 3-YEAR STUDY
Authors: SEREMETIS SV
Citation: Sv. Seremetis, VERY HIGH-PURITY VERSUS INTERMEDIATE-PURITY FACTOR-VIII IN HUMAN-IMMUNODEFICIENCY-VIRUS POSITIVE HEMOPHILIACS - CONCLUSIONS OF A PROSPECTIVE 3-YEAR STUDY, Seminars in hematology, 30(4), 1993, pp. 10-13
CONGENITAL BLEEDING DISORDERS - RATIONAL TREATMENT OPTIONS
Authors: SEREMETIS SV ALEDORT LM
Citation: Sv. Seremetis et Lm. Aledort, CONGENITAL BLEEDING DISORDERS - RATIONAL TREATMENT OPTIONS, Drugs, 45(4), 1993, pp. 541-547
Risultati: 1-11 |